HEMATOLOGICAL EFFECTS FROM RADIOIODINE TREATMENT OF THYROID-CARCINOMA

被引:17
作者
KELDSEN, N
MORTENSEN, BT
HANSEN, HS
机构
[1] RIGSHOSP,FINSEN INST,DEPT ONCOL,DK-2100 COPENHAGEN,DENMARK
[2] RIGSHOSP,FINSEN INST,DEPT INTERNAL MED,DK-2100 COPENHAGEN,DENMARK
关键词
THYROID CARCINOMA; RADIOIODINE TREATMENT; HEMATOLOGICAL EFFECTS; BONE MARROW CULTURE;
D O I
10.3109/02841869009091796
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The changes in peripheral blood counts and number of colony forming cells (CFU-c) in the bone marrow after I-131 treatment for thyroid cancer were followed in 24 patients. The median WBC declined to 78% and the median blood platelet count to 69% of the pretreatment values after 4 treatments. In 4 patients a moderate pancytopenia developed and in 1 patient additionally treated with chemotherapy and preleukaemia was suspected. In 19 bone marrow samples obtained from 13 patients no difference in number of CFU-c could be found related to cumulated I-131 activities given to those patients. In 5 of 7 patients examined between the 9th and the 19th day after a treatment the number of CFU-c had declined by 50% or more. It is concluded that radioiodine exerts a protracted suppressive effect on the bone marrow which is seldom severe. Agar culture of bone marrow cells with counting of CFU-c was not found to be more sensitive than the peripheral blood counts in predicting bone marrow damage and cannot be recommended for routine use.
引用
收藏
页码:1035 / 1039
页数:5
相关论文
共 12 条
[1]   TREATMENT OF THYROID-CARCINOMA WITH RADIOACTIVE IODINE [J].
BEIERWALTES, WH .
SEMINARS IN NUCLEAR MEDICINE, 1978, 8 (01) :79-94
[2]   INDUCTION OF LEUKEMIA BY I-131 TREATMENT OF THYROID-CARCINOMA [J].
BRINCKER, H ;
HANSEN, HS ;
ANDERSEN, AP .
BRITISH JOURNAL OF CANCER, 1973, 28 (03) :232-237
[3]   RADIOIODINE TREATMENT OF METASTATIC THYROID-CARCINOMA - THE ROYAL-MARSDEN-HOSPITAL EXPERIENCE [J].
BROWN, AP ;
GREENING, WP ;
MCCREADY, VR ;
SHAW, HJ ;
HARMER, CL .
BRITISH JOURNAL OF RADIOLOGY, 1984, 57 (676) :323-327
[4]   THE LONG-TERM HAZARDS OF THE TREATMENT OF THYROID-CANCER WITH RADIOIODINE [J].
EDMONDS, CJ ;
SMITH, T .
BRITISH JOURNAL OF RADIOLOGY, 1986, 59 (697) :45-51
[5]  
FLIEDNER TM, 1986, INT J RADIAT BIOL, V49, P35
[6]  
GUNTER HH, 1987, STRAHLENTHER ONKOL, V163, P475
[7]   ABSORBED DOSES IN MARROW DURING I-131 THERAPY [J].
MCEWAN, AC .
BRITISH JOURNAL OF RADIOLOGY, 1977, 50 (593) :329-331
[8]  
SCHOBER O, 1987, STRAHLENTHER ONKOL, V163, P464
[9]   BLOOD RADIOIODINE CONCENTRATION AND BLOOD RADIATION DOSAGE DURING I-131 THERAPY FOR METASTATIC THYROID CARCINOMA [J].
SEIDLIN, SM ;
YALOW, AA ;
SIEGEL, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1952, 12 (09) :1197-1204
[10]   THE METABOLIC FATE OF I-131 AFTER LARGE THERAPEUTIC DOSES IN PATIENTS WITH METASTATIC CARCINOMA OF THE THYROID [J].
STANBURY, JB ;
BROWNELL, GL ;
BARZELATTO, J ;
CORREA, J ;
MAISTERRENA, J ;
CORTAZAR, J ;
RODRIGUEZSOTO, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1952, 12 (11) :1480-1494